✦ LIBER ✦

107A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the larynx and pharynx

✍ Scribed by Cummings, B.J.; Keane, T.J.; Pintille, M.; O'Sullivan, B.; Payne, D.; Warde, P.; McLean, M.; Waldron, J.; Liu, F.F.; Gullane, P.

Book ID: 121889784
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 127 KB
Volume: 40
Category: Article
ISSN: 0167-8140
DOI: 10.1016/S0167-8140(96)80116-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperfractionated radiation therapy with

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vask 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 12 KB

42 Standard once-daily versus thrice-dai

42 Standard once-daily versus thrice-daily concomitant boost accelerated superfractionated irradiation for advanced squamous cell carcinoma of the head and neck: Preliminary results of a prospective randomized trial

✍ Christopher R. Johnson; Rupert K. Schmidt-Ullrich; Douglas W. Arthur; David T. H 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Postoperative radiation as adjuvant trea

Postoperative radiation as adjuvant treatment for carcinoma of the oral cavity larynx, and pharynx: Preliminary report of a prospective randomized trial

✍ William A. Kokal; James P. Neifeld; Donald Eisert; James A. Lipsett; Walter Lawr 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB

A prospective randomized trial was performed in patients with advanced squamous cell carcinomas (SCC) of the oral cavity, larynx, and pharynx to examine the effect of adjuvant postoperative radiation therapy on lo- coregional recurrence and survival following "curative" resection. Fiftyone patients

Hyperfractionated radiotherapy (Hfx RT)

Hyperfractionated radiotherapy (Hfx RT) with or without concurrent low-dose daily cisplatin (CDDP) in locally advanced unresectable squamous cell carcinoma of the head and neck (SCC H&N). A prospective randomized trial

✍ B. Jeremic; Y. Shibamoto; B. Milicic; N. Nikolic; A. Dagovic 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Radiation therapy alone or with concurre

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ Branislav Jeremic; Yuta Shibamoto; Bozidar Stanisavljevic; Ljubisa Milojevic; Bi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 986 KB

QOL for Advanced Squamous Cell Carcinoma

QOL for Advanced Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Randomized Trial of Tirapazamine, Cisplatin, and Radiation vs. Cisplatin and Radiation (TROG 02.02)

✍ J.G. Ringash; R. Fisher; L. Peters; J. Bourhis; J. Bernier; A. Trotti; J. Giralt 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB